[go: up one dir, main page]

UA94065C2 - Dihydropseudoerythromycin derivatives - Google Patents

Dihydropseudoerythromycin derivatives

Info

Publication number
UA94065C2
UA94065C2 UAA200806366A UAA200806366A UA94065C2 UA 94065 C2 UA94065 C2 UA 94065C2 UA A200806366 A UAA200806366 A UA A200806366A UA A200806366 A UAA200806366 A UA A200806366A UA 94065 C2 UA94065 C2 UA 94065C2
Authority
UA
Ukraine
Prior art keywords
dihydropseudoerythromycin
derivatives
dihydropseudoerythromycin derivatives
compounds
salts
Prior art date
Application number
UAA200806366A
Other languages
English (en)
Ukrainian (uk)
Inventor
Сатоши Омура
Тошияки Суназука
Кеничиро Нагаи
Хидеаки Шима
Харуко Ямабе
Original Assignee
Зе Китасато Инститьют
Афиникс, Инк.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зе Китасато Инститьют, Афиникс, Инк. filed Critical Зе Китасато Инститьют
Publication of UA94065C2 publication Critical patent/UA94065C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

Изобретение касается соединения, представленного формулой [I], где каждый радикал является таким, как определено в описании, или его фармацевтически приемлемой соли, а также фармацевтической композиции, которая содержит соединение как активный ингредиент.[I]
UAA200806366A 2005-10-14 2006-10-13 Dihydropseudoerythromycin derivatives UA94065C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005301070 2005-10-14

Publications (1)

Publication Number Publication Date
UA94065C2 true UA94065C2 (en) 2011-04-11

Family

ID=37942921

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200806366A UA94065C2 (en) 2005-10-14 2006-10-13 Dihydropseudoerythromycin derivatives

Country Status (18)

Country Link
US (1) US8133871B2 (ru)
EP (1) EP1950219B1 (ru)
JP (1) JP5118973B2 (ru)
KR (1) KR101384927B1 (ru)
CN (1) CN101326192B (ru)
AT (1) ATE513842T1 (ru)
AU (1) AU2006300215B2 (ru)
BR (1) BRPI0617391A2 (ru)
CA (1) CA2625055C (ru)
EA (1) EA015737B1 (ru)
ES (1) ES2369898T3 (ru)
IL (1) IL190643A (ru)
MY (1) MY147211A (ru)
NZ (1) NZ567772A (ru)
PL (1) PL1950219T3 (ru)
UA (1) UA94065C2 (ru)
WO (1) WO2007043710A1 (ru)
ZA (1) ZA200803414B (ru)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
AU2009207796B2 (en) 2008-01-25 2014-03-27 Grunenthal Gmbh Pharmaceutical dosage form
KR101690094B1 (ko) 2008-05-09 2016-12-27 그뤼넨탈 게엠베하 분무 응결 단계의 사용하에 중간 분말 제형 및 최종 고체 제형을 제조하는 방법
CA2765971C (en) 2009-07-22 2017-08-22 Gruenenthal Gmbh Hot-melt extruded controlled release dosage form
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
RU2604676C2 (ru) 2010-09-02 2016-12-10 Грюненталь Гмбх Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
PL2611425T3 (pl) 2010-09-02 2014-09-30 Gruenenthal Gmbh Odporna na ingerencję postać dawki zawierająca polimer anionowy
HRP20171458T1 (hr) 2011-07-29 2017-11-17 Grünenthal GmbH Tableta otporna na mijenjanje koja pruža neposredno oslobađanje lijeka
PL2736495T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
LT2838512T (lt) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
AR096438A1 (es) 2013-05-29 2015-12-30 Gruenenthal Gmbh Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
JP6445537B2 (ja) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング １個または複数の粒子を含有する改変防止（ｔａｍｐｅｒ−ｒｅｓｉｓｔａｎｔ）剤形
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
JP6480936B2 (ja) 2013-11-26 2019-03-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング クライオミリングによる粉末状医薬組成物の調製
JP2017518980A (ja) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング タペンタドールを含む、改変防止即時放出カプセル製剤
CN106456550A (zh) 2014-05-26 2017-02-22 格吕伦塔尔有限公司 避免乙醇剂量倾泻的多颗粒
CN107531737A (zh) * 2015-03-25 2018-01-02 哈佛大学的校长及成员们 脱氧糖胺的合成
KR20170139158A (ko) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
ATE316977T1 (de) * 2000-08-17 2006-02-15 Kitasato Inst Neue pseudoerythromycin derivate
US20020094962A1 (en) 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
AU2002225724A1 (en) * 2000-12-01 2002-07-08 Kosan Biosciences, Inc. Motilide compounds
US20040067896A1 (en) 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
JP4440108B2 (ja) 2002-10-29 2010-03-24 学校法人北里研究所 抗真菌活性増強作用を有する新規マクロライド誘導体

Also Published As

Publication number Publication date
EP1950219B1 (en) 2011-06-22
AU2006300215A1 (en) 2007-04-19
CA2625055C (en) 2013-12-24
US20090131341A1 (en) 2009-05-21
ATE513842T1 (de) 2011-07-15
KR101384927B1 (ko) 2014-04-11
CN101326192B (zh) 2012-06-20
ZA200803414B (en) 2009-09-30
CA2625055A1 (en) 2007-04-19
PL1950219T3 (pl) 2011-11-30
EA200801083A1 (ru) 2009-02-27
CN101326192A (zh) 2008-12-17
IL190643A (en) 2012-03-29
BRPI0617391A2 (pt) 2011-07-26
IL190643A0 (en) 2008-11-03
WO2007043710A1 (ja) 2007-04-19
MY147211A (en) 2012-11-14
JP5118973B2 (ja) 2013-01-16
EP1950219A1 (en) 2008-07-30
WO2007043710A9 (ja) 2007-06-07
ES2369898T3 (es) 2011-12-07
US8133871B2 (en) 2012-03-13
EA015737B1 (ru) 2011-10-31
NZ567772A (en) 2010-07-30
AU2006300215B2 (en) 2012-06-21
KR20080064861A (ko) 2008-07-09
JPWO2007043710A1 (ja) 2009-07-16
EP1950219A4 (en) 2010-02-03

Similar Documents

Publication Publication Date Title
UA94065C2 (en) Dihydropseudoerythromycin derivatives
TW200744588A (en) Pharmaceutical composition for external use
MX2007010072A (es) Derivados de piperidina antibacterianos.
TW200642689A (en) Immunosuppressive agent and anti-tumor agent comprising heterocyclic compound as active ingredient
WO2007061360A3 (en) Novel 3-bicyclocarbonylaminopyridine-2-carboxamides or 3-bicyclocarbonylaminopyrazine-2-carboxamides
TW200700393A (en) Novel cis-2,4,5-triaryl-imidazolines
TNSN08407A1 (en) Organic compounds
WO2008120725A1 (ja) 新規ピロリノン誘導体およびそれを含有する医薬組成物
SE0401971D0 (sv) Piperidne derivatives
MX2007003546A (es) Derivados de indozolona como inhibidores de 11-beta- hidroxiesteroide-deshidrogenasa.
WO2009060835A1 (ja) 新規ユビキリン結合性小分子
MX2009006334A (es) Derivados de heteroaril-pirrolidinil- y -piperidinil-cetona.
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
TW200626598A (en) Pyrrazolo-pyrimidine derivatives
TW200716628A (en) Novel compounds
MX2009013501A (es) Compuestos piperidinicos y sus usos.
UA96759C2 (en) 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS
WO2007099171A3 (en) Bicyclo-pyrazoles active as kinase inhibitors
MY144050A (en) Tetralin and indane derivatives and uses thereof
MX2009003169A (es) Derivados de sulfonamida.
WO2009075250A1 (ja) 植物病害防除剤
WO2007068728A3 (en) N-substituted pyrrolopyridinones active as kinase inhibitors
TW200730510A (en) Chroman compounds
MX2009001572A (es) Derivados de arilpiperazina y usos de los mismos.
TW200626567A (en) Benzoxazine and quinoxaline derivatives and uses